RV Rising News Network

• Business
• PR Newswire

Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG

rvrisingnetwork October 27, 2025 0

Novartis to acquire Avidity for USD 72.00 per share in cash for total equity value of approximately...

Read More Read more about Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG

• Business
• PR Newswire

Ribo kriegt von der EMA den Status als Orphan Drug für das siRNA-Therapeutikum RBD1016 gegen Hepatitis-Delta-Virus-Infektion (HDV)

rvrisingnetwork October 27, 2025 0

BEIJING und GOTHENBURG, Schweden, 26. Oktober 2025 /PRNewswire/ — Suzhou Ribo Life Science Co., Ltd. und Ribocure...

Read More Read more about Ribo kriegt von der EMA den Status als Orphan Drug für das siRNA-Therapeutikum RBD1016 gegen Hepatitis-Delta-Virus-Infektion (HDV)

• Business
• PR Newswire

138th Canton Fair Showcases Resilience of China’s Craft Ceramics and Glassware Industry

rvrisingnetwork October 27, 2025 0

GUANGZHOU, China, Oct. 26, 2025 /PRNewswire/ — At Phase 2 of the 138th China Import and Export...

Read More Read more about 138th Canton Fair Showcases Resilience of China’s Craft Ceramics and Glassware Industry

• PR Newswire
• World

138th Canton Fair Showcases Resilience of China’s Craft Ceramics and Glassware Industry

rvrisingnetwork October 27, 2025 0

GUANGZHOU, China, Oct. 26, 2025 /PRNewswire/ — At Phase 2 of the 138th China Import and Export...

Read More Read more about 138th Canton Fair Showcases Resilience of China’s Craft Ceramics and Glassware Industry

• News
• PR Newswire

Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions

rvrisingnetwork October 27, 2025 0

Long-term data shows significant and sustained blood pressure reductions in both office-based and 24-hour ambulatory blood pressure,...

Read More Read more about Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions

• Business
• PR Newswire

Innovent’s Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3

rvrisingnetwork October 27, 2025 0

The proportion of participants achieving HbA1c < 7.0% and a ≥10% reduction in body weight from baseline...

Read More Read more about Innovent’s Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3

• Business
• PR Newswire

Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025

rvrisingnetwork October 27, 2025 0

SHANGHAI and HONG KONG, Oct. 26, 2025 /PRNewswire/ — Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading...

Read More Read more about Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025

• PR Newswire
• World

2025 Yangtze River Cultural Festival Opens in Zhangjiagang, Jiangsu

rvrisingnetwork October 27, 2025 0

ZHANGJIAGANG, China, Oct. 26, 2025 /PRNewswire/ — On October 24, the 2025 Yangtze River Cultural Festival formally...

Read More Read more about 2025 Yangtze River Cultural Festival Opens in Zhangjiagang, Jiangsu

• Health
• PR Newswire

Health Canada Grants Authorization for Leqembi® (lecanemab)

rvrisingnetwork October 27, 2025 0

STOCKHOLM, Oct. 27, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that...

Read More Read more about Health Canada Grants Authorization for Leqembi® (lecanemab)

• Business
• PR Newswire

EU Climate Ambitions at Risk Flawed Regulatory Framework Threatens Shipping Innovation

rvrisingnetwork October 27, 2025 0

GOTHENBURG, Sweden, Oct. 27, 2025 /PRNewswire/ — I-Tech is a Swedish biotech company and developer of the...

Read More Read more about EU Climate Ambitions at Risk Flawed Regulatory Framework Threatens Shipping Innovation